Therapeutic potential of 2-isoxazolines

Indian Journal of Pharmaceutical Sciences

Volumn 66, Issue 4, 2004, Pages 377-381

  Imran, Mohd ^a   Khan, S A ^a   Siddiqui, N ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33751348486     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Dighade, S.R., Patil, S.D., Chincholkar, M.M. and Dighade, N.R., Asian J. Chem., 2003, 15, 450.
2. Kaur, H., Kumar, S., Renu, Manisha and Sangal, S.K., Acta. Cienc. Indica. Chem., 1999, 25, 49.
3. Naik, V.R. and Naik, H.J., Asian J. Chem., 2000, 12, 1358.
4. Tayde.V.B. and Jamode, V.S., Asian J. Chem., 1998, 10, 1021.
5. Kedar, R.M., Vidhale, N.N. and Chincholkar, M.M., Orient. J. Chem., 1997, 13, 153.
6. Vikani, H.J., Patel, P.H. and Parekh, H.H., J.lnst. Chem., 1996, 68, 21.
7. Tiwari, N., Dwivedi, B. and Nizamuddin., Bollet. Chim. Farmaceutico, 1989, 128, 332.
8. Barot, V.M., Orient. J. Chem., 2000, 16, 581.
9. Desai, J.K. and Ankhiwala, M.D., J. Inst. Chem., 1998, 70, 208.
10. Shinde, N.D., Shinde, D.B. and Shingare, M.S., Orient. J. Chem., 1995, 11, 169.
11. Barot, V.M., Modi, S.R. and Naik, H.B., J. Inst. Chem., 2000, 72, 48.
12. Otsuji, Y. and Mizuno, K., Jpn. Kokai Tokyo Koho, 1989, 6.
13. Khan, M.S.Y. and Bawa, S., Indian J. Chem., 2001, 40b, 1207.
14. Lee, H.J., You, K., Ko, D.H. and Yoon, K.J., Drugs Exptl. Clin. Res., 1998, 24, 57.
15. Shivkumar, B. and Nargund, L.V.G., Indian J. Heterocycl. Chem., 1998, 8, 27.
16. Kleinman, E.F. (Pfizer Inc., USA) U.S. U55, 716, 957, through Chem. Abstr., 1998, 128, 18040d, 567.
17. Wong, P.C., Quan, M.L., Crain, E.J., Watson, C.A., Wexler, R.R. and Knabb, R.M., J. Pharmacol. Exp. Ther., 2000, 292, 351.
18. Pruitt, J.R., Pinto, D.J., Estrella, M.J., Bostrom, L.L., Knabb, R.M., Wong, P.C., Wright, M.R. and Wexler, R.R., Bioorg. Med. Chem. Lett., 2000, 10, 685.
19. Quan, M.L., Liauw, A.Y., Pruitt, J.R., Carini, D.J., Bostrom, L.L., Huang, P.P., Knabb, R.M., Thoolen, M.J., Wong, P.C., Wexler, R.R. and Harrison, K., J. Med. Chem., 1999, 42, 2752.
20. Quan, M.L., Ellis, C.D., Liauw, A.Y., Alexander, R.S., Knabb, R.M., Wright, M.R., Wong, P.C. and Wexler, R.R., J.Med. Chem., 1999, 42, 2750.
21. Quan, M.L., Wityak, J., Galemmo, R.A.J., Stouten, P.F.W. and Pruitt, J.R. (Du Pont Merck Pharmaceutical Company, USA) PCT Int. Appl. W09723, 212, through Chem. Abstr., 1997, 127, 135788z, 618.
22. Smalheer, J.M., Wang, S. and Jadhav, P.K. (Du Pont Pharmaceutical Company, USA) PCT Int. Appl. W00029, 406, through Chem. Abstr., 2000, 133, 4648e, 581.
23. Wityak, J., Xue, C.B. and Sielecki, D.T.M. (The Du Pont Merck Pharmaceutical Company, USA) U.S. US 5,849, 736, through Chem. Abstr., 1999, 130, 66484v, 715.
24. Wityak, J., Cain, G.A., Batt, D.G. and Hussain, M.A. (Du Pont Merck Pharmaceutical Company, USA) PCT Int. Appl. W09638, 426, through Chem. Abstr., 1997, 126, 117965e, 589.
25. Wityak, J. and Jadhav, P.K. (Du Pont Pharmaceutical Company, USA) PCT Int. Appl. W00029, 407, through Chem. Abstr., 2000, 132, 347558c, 626.
26. Sielecki, T.M., Wityak, J., Liu, J., Mousa, S.A., Thoolen, M., Wexler, R.R. and Olson, R.E., Bioorg. Med. Chem. Lett., 2000, 10, 449.
27. Mousa, S.A., Olson, R.E., Bozarth, J.M., Lorelli, W., Forsythe, M.S., Racanelli, A., Gibbs, S., Schlingman, K., Wityak, J., Sielecki, T.M., Anderson, P.S. and Friedman, P.A., J. Cardiovasc. Pharmacol., 1998, 32, 169.
28. Mousa, S.A. and Wityak, J., Cardiovasc. Drug Rev., 1998, 16, 48.
29. Xue, C.B., Wityak, J., Sielecki, T.M. and Pinto, D.J., J. Med. Chem., 1997, 40, 2064.
30. Olson, R.E., Sielecki, T.M., Wityak, J. and Pinto, D.J., J. Med. Chem., 1999, 42, 1157.
31. Olson, R.E., Sielecki, T.M., Wityak, J. and Pinto, D.J., Actu. Chim. Ther., 1999, 25, 19.
32. Cohan, V.L. and Kleinman, E.F. (Pfizer Inc.) PCT Int. Appl. W09524, 398, through Chem. Abstr., 1996, 124, 117297x, 1262.
33. Cohan, V.L. and Kleinman, E.F. (Pfizer Inc., USA) U.S. US6, 114, 367, through Chem. Abstr., 2000, 133, 222722r, 682.
34. Delcorral, J.M.M., Gordaliza, M., Castro, M.A., Lopez, V.M.L., Garicia, G.M.D., Broughton, H.B. and Feliciano, A.S., Tetrahedron, 1997, 53, 6555.
35. Simoni, O., Manfredini, S., Tabrizi, M.A. and Bazzanini, R., Top. Mol. Org. Engg., 1991, 8, 119.
36. Kim, E.E.K., Park, M.J., Park, T.K. and Moon, K.Y. (LC Chemical Ltd., S. Korea) PCT Int. Appl. W00121, 600, through Chem. Abstr., 2001, 134, 262851j, 276.
37. Park, T.K., Chang, H.K., Moon, K.Y. and Kim, E.E.K. (LC Chemical Ltd., S. Korea) PCT Int. Appl. W00121, 599, through Chem. Abstr., 2001, 134, 266298g, 682.
38. Srivastava, S., Bajpai, L.K., Sanjay, B., Bhaduri, A.P., Maikhuri, J.P., Gupta, G. and Dhar, J.D., Bioorg. Med. Chem., 1999, 7, 2607.
39. Murai, Y., Nishikawa, M., Ueda, Y. and Onomura, O.T.I. (Daicel Chemical Industries Ltd.) PCT Int. Appl. W09523, 793, through Chem. Abstr., 1996, 124, 117296w, 1261.
40. Chung, Y.J., Kim, D.H., Choi, K.Y. and Kim, B.H., Korean J. Med. Chem., 1995, 5, 141.
41. Pan, S., Amankulo, N.M. and Zhaok, Tetrahedron, 1998, 54, 6587.
42. Andres-Gil, J.I., Fernandez, G.F.J, and Alcazar, V.M.J. (Janssen Pharmaceutica N.V., Belg.) PCT Int. Appl.W00266, 484, through Chem. Abstr., 2002, 137, 201298z, 827.
43. Chalquest, R.R. (Akkadix Corporation, USA) PCT Int. Appl. W00154, 505, through Chem. Abstr., 2001, 135, 132416f, 131.
44. De Amici, M., Conti, P., Vistoli, G., Carea, G., Ottolina, G. and De Michelic, C., Med. Chem. Res., 2001, 10, 615.
45. Lukevics, E., Arsenyan, P. and Veveris, M., Met. Based Drugs, 1998, 5, 2517.
46. Schwab, W., Angnostopulos, H., Ryder, B.R., Schleyerbach, R. and Weithmann, K. (Hoechst A-G) Ger. Offen. DE4, 408, 084, through Chem. Abstr., 1996, 124, 86996t, 1312.